Sugi Predict

Sugi Predict / Compounds / SCHEMBL3674285

SCHEMBL3674285

SCHEMBL3674285

c1ccc([PH](c2ccccc2)(c2ccccc2)C2CCCCC2)cc1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.34
▸ SLC18A3 Q16572 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ GAA P10253 2/20 0.33
▸ EPHX2 P34913 3/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ PRCP P42785 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445014 1.00 IDO1 (0.34) IDO1SLC18A3HPGDALDH1A1GAA
SCHEMBL23563764 1.00 IDO1 (0.34) IDO1SLC18A3HPGDALDH1A1GAA
Bromide SCHEMBL5723432 0.98 IDO1 (0.33) IDO1SLC18A3HPGDALDH1A1GAA
Hydrochloric Acid SCHEMBL27574177 0.98 IDO1 (0.36) IDO1SLC18A3HPGDALDH1A1GAA
SCHEMBL8299920 0.98 ALDH1A1 (0.34) IDO1SLC18A3HPGDALDH1A1GAA
Bromide SCHEMBL5723575 0.95 GAA (0.33) IDO1SLC18A3HPGDALDH1A1GAA
SCHEMBL8403993 0.93 OPRM1 (0.34) ALDH1A1GAAHTT
SCHEMBL9482285 0.92 ALDH1A1 (0.33) IDO1SLC18A3HPGDALDH1A1GAA
Oxalic Acid SCHEMBL7632154 0.90 TAAR1 (0.42) HPGDALDH1A1EPHX2RAB9AKDM4E
Oxalic Acid SCHEMBL7626635 0.90 TAAR1 (0.42) HPGDALDH1A1EPHX2RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728843-B1 Interference-free redox detection system DADE BEHRING MARBURG GMBH (DE) 2003-04-23 — — EP claimed
EP-0329021-B1 Preparation of advanced epoxy resins and dihydric phenols in the presence of phosphonium compounds DOW CHEMICAL CO (US) 1994-01-26 — — EP claimed
CN-119308018-A Chiral zinc-based metal halide monocrystal material and preparation method and application thereof 江西铜业技术研究院有限公司 2025-01-14 — — CN disclosed
CN-117861717-A Hydrodesulfurization catalyst and preparation method and application thereof 中国石油化工股份有限公司 2024-04-12 — — CN disclosed
US-20230374038-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2023-11-23 — — US disclosed
US-20230374038-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2023-11-23 — — US disclosed
WO-2023196429-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-12 — — WO disclosed
CN-115672332-A Papermaking black liquor lignin conversion catalyst and preparation method and application thereof 中国石油大学(华东) 2023-02-03 — — CN disclosed
WO-2022076620-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
US-9939729-B2 Resist pattern-forming method JSR CORPORATION (JP) 2018-04-10 — — US disclosed
US-9766547-B2 Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device FUJIFILM CORPORATION (JP) 2017-09-19 — — US disclosed
EP-0718712-B1 Quaternary phosphonium trihalocuprate salts as charge-control agents for toners and developers EASTMAN KODAK CO (US) 1999-03-10 — — EP disclosed
EP-0718707-B1 Quaternary phosphonium trihalozincate salts as charge-control agents for toners and developers EASTMAN KODAK CO (US) 1998-03-04 — — EP disclosed
CN-1172490-A Process for the preparation of polycarbonates IDEMITSU KOSAN CO (JP) 1998-02-04 — — CN disclosed
EP-0807657-A1 PROCESS FOR PRODUCING POLYCARBONATE IDEMITSU KOSAN COMPANY LIMITED (JP) 1997-11-19 — — EP disclosed
US-5561020-A THERMALLY STABLE, UNIFORMLY DISPERSIBLE EASTMAN KODAK COMPANY (US) 1996-10-01 — — US disclosed
US-5547803-A Quaternary phosphonium trihalocuprate salts as charge-control agents for toners and developers EASTMAN KODAK COMPANY (US) 1996-08-20 — — US disclosed
EP-0718712-A1 Quaternary phosphonium trihalocuprate salts as charge-control agents for toners and developers EASTMAN KODAK COMPANY (US) 1996-06-26 — — EP disclosed
EP-0718707-A1 Quaternary phosphonium trihalozincate salts as charge-control agents for toners and developers EASTMAN KODAK COMPANY (US) 1996-06-26 — — EP disclosed
US-5118822-A Olefin epoxidation using a perrhenate catalyst and an organic hydroperoxide ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1992-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230374038-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1G, SCNN1B IDO1 4752/4885SLC18A3 676/4885HPGD 1495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.